The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Self-identified transgender women, transgender men, or non-binary persons
• Age ≥18 years
• HIV-negative
• Engaged in chemsex or substance use within past 12 months
• Able to provide informed consent
Locations
Other Locations
Thailand
Tangerine Clinic, Institute of HIV Research and Innovation
RECRUITING
Pathum Wan
Contact Information
Primary
Nittaya Phanuphak, MD,PhD.
nittaya.p@ihri.org
6681 825 3544
Backup
Rena Janamnuaysook, MBA
rena.j@ihri.org
6698 516 4562
Time Frame
Start Date: 2024-02-01
Estimated Completion Date: 2028-02-01
Participants
Target number of participants: 140
Treatments
Other: Transgender-tailored Harm Reduction Service
Participants (transgender women, transgender men, and non-binary persons engaging in chemsex or substance use) will receive a comprehensive, transgender-tailored harm reduction service over a 12-month follow-up period. The intervention includes substance use harm reduction, sexual health services including HIV pre-exposure prophylaxis (PrEP), mental health screening and support, and socio-legal assistance. Participants will attend study visits at baseline and months 3, 6, 9, and 12, with assessments of behavioral risks, substance use, mental health, HIV/STI testing, and social outcomes.
Sponsors
Leads: Institute of HIV Research and Innovation Foundation, Thailand